RGEN

#1067
Repligen Corp
131.9300 USD
+0.69%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
131.9300
131.9300
Yıllık Aralık
109.6600
175.5700
Günlük Değişim
+0.69%
Aylık Değişim
+12.61%
6 Aylık Değişim
-20.38%
Yıllık Değişim
-20.38%
Önceki Kapanış
131.0300
Açılış
131.9300
Bid
Ask
Düşük
131.9300
High
131.9300
Hacim
146
Tam grafiği aç

Financials

Genel Bakış Tablolar İstatistikler
Çeyreklik Yıllık
  • Market Capitalization 7.4318 B
  • Employee 2 000
  • Founded 1981
  • CEO Tony J. Hunt
  • Website www.repligen.com
  • Headquarter Delaware, United States
  • FIGI BBG000BS48J3
  • Industry Tıbbi Aletler ve Malzemeler
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Total debt
Free cash flow
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
190.53
Price to sales ratio
0.01

Repligen Corporation

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations worldwide.

Haberler